The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC).
Asim Amin
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (I)
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Elizabeth R. Plimack
Research Funding - Bristol-Myers Squibb
Jeffrey R. Infante
No relevant relationships to disclose
Marc S. Ernstoff
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Brian I. Rini
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pfizer
Research Funding - Acceleron Pharma; Bristol-Myers Squibb; GlaxoSmithKline; immatics; Merck; Millennium; Pfizer
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Jennifer J. Knox
Consultant or Advisory Role - AVEO
Research Funding - Pfizer
Sumanta Kumar Pal
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Martin Henner Voss
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Padmanee Sharma
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; Jounce Therapeutics; MedImmune
Stock Ownership - Jounce Therapeutics
Research Funding - Bristol-Myers Squibb
Christian K. Kollmannsberger
Stock Ownership - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
Jennifer L. Spratlin
No relevant relationships to disclose
Yun Shen
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (B)
John F. Kurland
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Paul Gagnier
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Hans J. Hammers
Research Funding - Bristol-Myers Squibb